NYSE: CYHCommunity Health Systems Inc Stock
$2.43+0.02 (+0.83%)
Updated Apr 23, 2025
Community Health Systems shares are... find out Why CYH Price Moved with a free WallStreetZen account
Why Price MovedCYH Price
$2.43
Fair Value Price
N/A
Market Cap
$337.58M
52 Week Low
$2.24
52 Week High
$6.29
P/E
-0.62x
P/B
-0.18x
P/S
0.03x
PEG
N/A
Dividend Yield
N/A
Revenue
$12.63B
Earnings
-$516.00M
Gross Margin
84.6%
Operating Margin
3.35%
Profit Margin
-4.1%
Debt to Equity
-8.03
Operating Cash Flow
$480M
Beta
1.43
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
CYH Overview
Community Health Systems Inc ("CHS") provides general hospital healthcare services in the U.S. In 2014, CHS operated 200 hospitals, but that number declined to 85 in 2021. The company also owns four home health agencies and provides management and consulting services to independent hospitals. CHS was founded in 1985 and is based in Franklin, TN.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CYH's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Care Facility
Industry Rating
B
CYH
Ranked#29 of 42
Ranked#29 of 42
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $12.27 | A | |
| $12.30 | A | |
| $166.79 | A |
Be the first to know about important CYH news, forecast changes, insider trades & much more!
CYH News
Overview
Due Diligence Score
–
Industry Average (30)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CYH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CYH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CYH is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
CYH's Earnings (EBIT) of $423.00M... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more CYH due diligence checks available for Premium users.
Valuation
CYH price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-0.62x
Industry
14.84x
Market
26.95x
CYH price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.18x
Industry
4.2x
CYH's financial health
Profit margin
Revenue
$3.3B
Net Income
-$70.0M
Profit Margin
-2.1%
CYH's Earnings (EBIT) of $423.00M... subscribe to Premium to read more.
Interest Coverage Financials
CYH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$14.1B
Liabilities
$15.4B
Debt to equity
-8.03
CYH's short-term assets ($3.30B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CYH's long-term liabilities ($13.03B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CYH's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CYH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$216.0M
Investing
-$143.0M
Financing
-$69.0M
CYH's operating cash flow ($480.00M)... subscribe to Premium to read more.
Debt Coverage Financials
CYH vs Medical Care Facility Stocks
Community Health Systems Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.